Central retinal vein occlusion risk profile: A case-control study

European Journal of Ophthalmology

Volumn 13, Issue 5, 2003, Pages 445-452

  Shahsuvaryan, Marianne L ^a,c   Melkonyan, A K ^b  

^a Ophthalmologic Centre   (Armenia)

^b PROMTEST Lmt   (Armenia)

^c NONE   (Armenia)

Author keywords

Case control study; Central retinal vein occlusion; Risk factors

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CASE CONTROL STUDY; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ERYTHROCYTE SEDIMENTATION RATE; EYE PROTECTION; FEMALE; GLAUCOMA; HIGH RISK POPULATION; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; URBAN AREA;

EID: 0038786810     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210301300505     Document Type: Article

References (47)

1. Fong AC, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol 1993; 37: 393-417.
2. Giuffré G, Randazzo PG, Palumbo C. Central retinal vein occlusion in young people. Doc Ophthalmol 1992; 80: 127-32.
3. Snyers B, Serckx JP. Occlusion of the central retinal vein in young adults: risk factors and visual prognosis. Bull Soc Belge Ophtalmol 1993; 250: 51-8.
4. Gupta A, Agarwal A, Bansal RK, Agarwal AT, Chugh KS. Ischaemic central retinal vein occlusion in the young. Eye 1993; 7: 138-42.
5. Fong AC, Schatz H, McDonald HR, et al. Central retinal vein occlusion in young adults (papillophlebitis). Retina 1992; 12: 3-11.
6. Messerli J, Flammer J. Central vein thrombosis in younger patients. Klin Monatsbl Augenheilkd 1996; 208: 303-5.
7. Spires R. Central retinal vein occlusion. J Ophthalmic Nurs Technol 1993; 12: 57-63.
8. Robinson MK, Halpern JI. Retinal vein occlusion. Am Fam Physician 1992; 45: 2661-6.
9. Chen JC, Klein ML, Watzke RC, Handelman IL, Robertson JE. Natural course of perfused central retinal vein occlusion. Can J Ophthalmol 1994; 30: 21-4.
10. Hayreh SS. Retinal vein occlusion. Indian J Ophthalmol 1994; 42: 109-32.
11. Gaudric A. Occlusion of the central retinal vein and its branches. Etiology, diagnosis, course, prognosis, treatment. Rev Prat 1994; 44: 1228-32.
12. Alghadyan AA. Retinal vein occlusion in Saudi Arabia: possible role of dehydration. Ann Ophthalmol 1993; 25: 294-8.
13. Prunte C, Gasser P. Diagnosis of vascular occlusion of the posterior eye segment. Klin Monatsbl Augenheilkd 1993; 202: 376-8.
14. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117: 429-41.
15. Mitchell P, Smith W, Chang A. The Blue Mountains Eye Study. Prevalence and associations of retinal vein occlusion in Australia. Arch Ophthalmol 1996; 114: 1243-7.
16. Tsaloumas MD, Kirwan J, Vinall H, et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Br J Ophthalmol 2000; 14: 821-7.
17. Lang GE, Handel A. Clinical and fluorescein angiography changes in patients with central retinal vein occlusion. A unicenter study of 125 patients. Klin Monatsbl Augenheilkd 1992; 201: 302-8.
18. Glacet Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 1996; 103: 551-60.
19. Teoh SL, Amarjeet K. A comparative study of branch retinal vein occlusion and central vein occlusion amongst Malaysian patients. Med J Malaysia 1993; 48: 410-5.
20. Elman MJ, Bhatt AK, Quinlan PM, Enger C. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology 1990; 90: 1543-8.
21. Rath EZ, Frank RN, Shin DH, Kim C. Risk factors for retinal vein occlusions: a case-control study. Ophthalmology 1992; 99: 509-14.
22. The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996; 114: 545-54.
23. Lang GE, Spraul CW. Risk factors for retinal vein occlusive diseases. Klin Monatsbl Augenheilkd 1997; 211: 217-26.
24. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981; 79: 371-422.
25. Verougstraete C. Is change of the vessel wall a risk factor for venous thrombosis? Lancet 1999; 353: 2158.
26. Williamson TH, Rumley A, Lowe GDO. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 1996; 80: 203-8.
27. Arend O, Remky A, Jung F, Kiesewetter H, Reim M, Wolf S. Role of rheologic factors in patients with acute central retinal vein occlusion. Ophthalmology 1996; 103: 80-6.
28. Bandello F, D'Angelo SV, Parlavecchia M, et al. Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion. Thromb Haemost 1994; 72: 39-43.
29. Lip PL, Blann AD, Jones AF, Lip GY. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Eye 1998; 12: 245-51.
30. Fegan CD. Central retinal vein occlusion and thrombophilia. Eye 2002; 16: 98-106.
31. Brown BA, Marx JL, Ward TP, et al. Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology 2002; 109: 287-90.
32. Marcucci R, Bertini L, Giusti B, et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 2001; 86: 772-6.
33. Vine AK, Samama MM. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol 1993; 37: 283-92.
34. Beaumont PE, Kang HK. Pattern of vascular nonperfusion in retinal venous occlusions occurring within the optic nerve with and without optic nerve head swelling. Arch Ophthalmol 2000; 118: 1357-63.
35. Guven D, Sayinalp N, Kalayci D, Dundar S, Hasiripi H. Risk factors in central retinal vein occlusion and activated protein C resistance. Eur J Ophthalmol 1999; 9: 43-8.
36. Rondeau M, Weber JC, Martinot M, Meyer L, Sahel J, Storck D. Extra-ocular etiologic factors in retinal vein occlusion. Retrospective study of 24 patients. Rev Med Interne 2000; 21: 231-5.
37. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001; 131: 61-77.
38. Dodson PM, Kritzinger EE, Clough CG. Diabetes mellitus and retinal vein occlusion in patients of Asian, West Indians and white European origin. Eye 1992; 6: 66-8.
39. Dodson PM, Clough CG, Downes SM, Kritzinger EE. Does type II diabetes predispose to retinal vein occlusion. Eur J Ophthalmol 1993; 3: 109-13.
40. Mansour AM, Walsh JB, Henkind P. Mortality and morbidity in patients with central retinal vein occlusion. Ophthalmologica 1992; 204: 199-203.
41. Abu El Asrar AM, Abdel Gader AG, Al Amro S, Al Momen AK. Hypercoagulable states in patients with retinal venous occlusion. Doc Ophthalmol 1998; 95: 133-43.
42. Hayreh S, Zimmerman B, Podhajsky P. Hematologic abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002; 240: 180-96.
43. Fruschelli M, Puccetti L, Bruni F, Auteri A. Coagulative, fibrinolytic and metabolic pattern in patients with central retinal vein occlusion. Ophthalmologica 2002; 216: 108-12.
44. Appiah AP, Trempe CL. Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophthalmol 1989; 21: 153-7.
45. Hirota A, Mishima HK, Kiuchi Y. Incidence of retinal vein occlusion at the Glaucoma Clinic of Hiroshima University. Ophthalmologica 1997; 211: 288-91.
46. Saninoiu M. The relation between retinal venous occlusion and glaucoma. Oftalmologia 1992; 36: 163-71.
47. Sonnsjo B, Krakau CE. Arguments for a vascular glaucoma etiology. Acta Ophthalmol 1993; 71: 433-44.